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Three monoclonal antibodies (mAbs) recognizing distinct epitopes on the &subunit of beef heart mitochondrial F,-ATP- 
ase were studied for their reactivity towards the h-subunit both in isolated F, and in the F,-F, complex of submitochon- 
drial particles. Two of the antibodies termed mAb 8195 and mAb 6239 had free access to 8 in F, and the F,,-F, complex. 
Partial hindrance was observed for the third antibody mAb 822. By a double antibinding assay, it was found that the 
binding sites for mAb 8195 and mAb 6239 were close to each other and possibly overlapping. Mapping studies conducted 
with the isolated &subunit showed that mAb 6195 and mAb 6239 interacted with the N-terminal portion of ii extending 
from Ala-l to Met-16, whereas mAb 822 interacted with the fragment spanning Ser-17-Glu-68. It was concluded that 
the Ala-l-Met-16 segment of the &subunit in F, and the F,-F, complex is freely accessible from the outside, whereas 
the Ser-17Glu-68 segment of 8 is partially hidden, possibly as a result of interactions with other subunits. 
Monoclonal antibody; ATPase, F,- 
1. INTRODUCTION 
Monoclonal antibodies (mAbs) have recently 
been used to explore the structural organization 
and the function of the various subunits of 
Fi-ATPases isolated from mitochondria of pig 
heart [ 1,2], beef heart [3], and yeasts [4,5], and 
from chloroplasts [6] and Escherichia coli [7-lo]. 
Except in the case of E. coli Fr, where the small 
subunits y, S and 6 have been explored, all other 
studies have been carried out with mAbs directed 
against the major subunits, namely (Y and 8. In ex- 
periments aimed at characterizing the topography 
of the small mitochondrial Fi subunits, we have 
prepared mAbs against the S-subunit of beef heart 
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mitochondria. We have explored the accessibility 
of the specific epitopes to these mAbs in FI and the 
Fo-Fi complex, and mapped these epitopes on the 
J-subunit. 
2. MATERIALS AND METHODS 
Fi purified from beef heart submitochondrial particles [ll] 
was dissociated into an cuy& complex and the b-subunit. The 
a+ complex, free of the @ubunit, was recovered by DE-52 
chromatography [12]. The (YY& complex was supplemented 
with a fraction of Fi enriched in k subunits [13], and injected 
into the foot pad of three high responder Biozzi’s mice with 
complete Freund’s adjuvant. Two booster injections were given 
after three and six weeks. The mouse with the highest antibody 
titer to ~$6 complex received a last intravenous boost three 
days before fusion. Preparation of hybridomas, immunoen- 
zymatic screening of culture supernatants, mAbs production by 
ascitic fluids and determination of the mAb classes and 
subclasses were performed as described [14]. mAbs were screen- 
ed using biotinylated Fi subunits reacting via avidin interaction 
with biotinylated acetylcholinesterase [14]. 
Biotinylation of Fi subunits was performed as follows. An 
aliquot of 400~1 of the cry& complex enriched with 6 and c 
(1 mg/ml) subunits was incubated with 0.1 mM biotin N- 
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hydroxysuccinimide ster (IBF France) in 1 M sodium car- 
bonate buffer, pH 9.1. After 30 min at room temperature, the 
reaction was stopped by addition of 10 ~1 of 0.5 M ammonium 
acetate, pH 7.1, and the biotinylated proteins were separated 
from free biotin by dialysis. To check the effectiveness of 
biotinylation, the reacted subunits were separated by SDS- 
polyacrylamide gel electrophoresis and electrotransferred onto 
a nitrocellulose sheet (0.45 pm, Schleicher and Schiill). The 
transferred proteins were then reacted with an avidin- 
peroxidase complex and then revealed with diaminobenzidine in 
the presence of nickel and cobalt salts [15]. 
Screening of mAbs with the biotinylated Fr subunits was per- 
formed in two steps. In a first step, the biotinylated subunits 
were reacted with mAbs previously immobilized on a solid- 
phase coated with anti-mouse antiglobulins. In a second step, 
biotinylated AChE was linked to the immobilized system by 
means of avidin [14], and the bound AChE was revealed by a 
calorimetric assay based on the use of Ellman’s reagent [16]. 
This method proved to be sensitive and convenient for extensive 
screening. Positive clones were further characterized by 
Western blot using unmodified FI. Absence of reactivity of the 
preimmune serum against the biotinylated Fi subunits was 
verified. The mAbs were recovered from the ascitic fluids by 
precipitation with 50% saturated ammonium sulfate and fur- 
ther purified by affinity chromatography, using a column of 
protein A-Sepharose, equilibrated with a 0.14 M Na phosphate 
buffer, pH 8.1. mAbs of the IgGi and IgGz classes were eluted 
with a 0.14 M Na phosphate buffer of pH 6.0 and 4.3, respec- 
tively, and the eluates were neutralized by dropwise addition of 
1 M NaOH 1171. When used in enzymatic assays, purified 
mAbs were freed of Pi by centrifugation-filtration on short col- 
umns of Sephadex GSO [18]. Other determinations pertaining to 
protein concentration [19], total ATPase activity and 
oligomycin-sensitive ATPase activity [20] were carried out as 
described. Reconstitution of oligomycin-sensitive ATPase ac- 
tivity was performed by adding Fr in the presence of OSCP to 
urea-extracted submitochondrial particles, devoid of Fi [21]. In 
brief, Fi was first incubated for 30 min at room temperature 
with the different mAbs at concentration ratios of Fi to mAb 
ranging from 0.2 to 2 (mol/mol), and the immunoreacted FI 
was rebound to urea-treated particles in the presence of OSCP 
WI. 
For mapping studies, the J-subunit was cleaved at methionyl 
residues by treatment with a IO-fold excess of CNBr in 80% for- 
mic acid under nitrogen for 5 h at 37°C. Fragmentation by the 
V8 protease was achieved by incubation with the enzyme (1: 50, 
w/w) in 100 mM ammonium bicarbonate for 15 h at 37°C. Fi 
subunits and fragments of the &subunit were separated by SDS- 
polyacrylamide gel electrophoresis as described in [22] and [23], 
respectively. Treatment of the gels to remove SDS, elec- 
trophoretic transfer to nitrocellulose and immunochemical 
detection were as described in [24]. 
3. RESULTS AND DISCUSSION 
Injection of mice or rabbits with mitochondrial 
Fr resulted in the production of antibodies 
predominantly directed against the ,&subunit (un- 
published). As we were interested in mAbs directed 
224 
against the minor Fi subunits and particularly the 
S-subunit, immunization of mice was carried out 
with a subunit mixture of beef heart Fr deprived of 
the P-subunit and enriched in S- and e-subunits. 
3.1. Characterization of anti-d mAbs 
In a first step, using the AChE-avidin-biotin 
ELISA system described in [ 141, twenty clones pro- 
ducing anti-F1 mAbs were selected for study. These 
clones were cultured and injected intraperitoneally 
Fig. 1. Specificity of the monoclonal antid antibodies. After 
SDS-polyacrylamide gel electrophoresis of Fi (5 ,ug per track), 
the separated subunits were transferred onto nitrocellulose and 
incubated with a lOOOO-fold iluted solution of mAb initially at 
0.4 mg/ml. After an hour of incubation at room temperature, 
the bound mAbs were revealed, using a peroxidase conjugated 
goat anti-mouse immunoglobulin. Lanes: A, Coomassie blue 
staining of the gels; B, immunocharacterization of the 
transferred Fi subunits tested with mAb 622, mAb 6195 and 
mAb 6239. Blotting and immunodetection are described in 
section 2. 
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Fig.2. Immunoreactivity of mAb 622, 6195 and 6239 with FI and isolated 6, assayed by ELISA. ELISA plates (NUNC) were coated 
with 500 ng of purified Fi (panel A) or 60 ng of purified &subunit (panel B) per well in 150 ~1 of phosphate buffer. Reactions were 
further carried out with purified mAbs added in 150~1 of phosphate buffer as indicated. (0) mAb 622; (A) mAb 6195; (m) mAb 
6239. Bound antibodies were revealed using a peroxidase conjugated anti-mouse immunoglobulin and tetramethylbenzidine as 
peroxidase substrate. 
into mice primed with incomplete Freund’s adju- 
vant. The specificity of the ascites fluids against 
the Fr subunits was tested by Western blotting, 
followed by visualization of the immune complex 
by the peroxidase method (cf. section 2). Under 
these conditions, only three out of the twenty 
ascitic fluids were found to immunoreact with the 
S-subunit. The mAbs contained in these fluids were 
purified by affinity chromatography and their im- 
munoreactivity was again tested by Western blot 
(fig. 1). 
The three mAbs were referred to as mAb 622, 
mAb 6195 and mAb S239. The first mAb cor- 
responded to the IgG2k isotype and the other two 
to the IgGrk isotype. All of them were highly 
specific for the beef heart &subunit, and showed 
no reactivity towards the corresponding subunits 
from Saccharomyces cerevisiae F1 and Escherichia 
coli Fi. Their accessibility to specific epitopes in 
the a-subunit within isolated Fi or the Fo-FI com- 
plex in submitochondrial particles was assayed by 
ELISA, and compared to their reactivity towards 
isolated 6. Whereas the three mAbs reacted with 
the same efficiencies with isolated 6, mAb 6195 and 
mAb S239 displayed a much higher reactivity 
against Fi than mAb 822 did (fig.2). The same 
observation holds for the Fo-Fi complex (not 
shown). 
These results indicate that the epitopes of 
isolated 6 which are recognized by mAb 6195 and 
Table 1 
ELISA additivity assay to test simultaneous binding of mAbs 
on epitopes of the g-subunit 
mAb 
mAb 622 
mAb 6195 
mAb 6239 
mAb 622 + 
mAb 6195 
mAb 622 + 
mAb 6239 
mAb 6195 + 
mAb 6239 
Absorbancy Theoretical Additivity 
at 450 nm sum of index 
absorbancies 
0.380 - - 
0.835 - _ 
0.870 - - 
1.140 1.215 87 
1.120 1.250 79 
1.220 1.705 43 
Experimental conditions are as described in fig.2. The dilution 
used for each purified mAb corresponded to the lowest 
concentration at which saturation of 6 was achieved. The 
theoretical sum of absorbancies (A) is the sum of absorbancies 
obtained for each mAb alone. The additivity index AI was 
calculated as described in section 3 
225 
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mAb 6239 are also accessible in the &subunit 
associated to the other subunits within Fr or the 
Fo-Fi complex. In contrast, the epitope recognized 
by mAb 822 is partially hindered in isolated Fi and 
the Fo-Fr complex. The free access of mAb 6195 
and mAb 6239 to their epitopes on the a-subunit in 
the FI-FO complex indicates that these epitopes are 
not sequestered or hidden between the Fr and FO 
sectors. 
The three mAbs affected neither the Fi-ATPase 
17K- 
15 K-e 
8.1 K-m 
6.2K- 
2.5 K- 
822 
activity, nor the oligomycin-sensitive ATPase ac- 
tivity of the Fo-FI complex of submitochondrial 
particles. Even when incubated with isolated Fr for 
30 min at a mAb to Fi ratio of 4, they did not im- 
pair to any extent the reconstitution of the 
oligomycin-sensitive ATPase activity. The epitopes 
recognized by these mAbs are therefore not in- 
volved in the catalytic events of ATP hydrolysis; 
neither do they contribute to the binding of Fr to 
Fo. 
6195 s 239 
. . . . . . . CB2+ C63 
. . 
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Fig.3. Immunoreactivity pattern of the peptides obtained by CNBr cleavage of the isolated subunit. CNBr fragments of the J-subunit 
were separated by SDS-polyacrylamide gel electrophoresis and then electrotransferred onto nitrocellulose. Lane A corresponds to the 
control J-subunit incubated with a mixture.of mAbs 622, 6195 and 6239. The three B lanes correspond to 6 cleaved with CNBr and 
then reacted with each of the three mAbs. The molecular masses of reference proteins are designated by arrows. A schematic 
representation of the cleavage sites of the &subunit (146 amino acid residues) is given below the blots. 
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Met 16 Met 102 Glu 146 
A1a l7 -7 
I Ser 17 Glu 68 
c 1 
t 
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Fig.4. Scheme illustrating the reactivity of mAb 622, mAb 6195 and mAb 6239 against different segments of the &subunit. The hatched 
segment, Ala-1-Met-16, corresponds to the readily accessible portion of the a-subunit in Ft or the Fe-F, complex (for details see text). 
3.2. Mapping of the epitopes of the J-subunit 
reacting against mAb 622, mAb 8195 and 
mAb 6299 
To test whether the epitopes recognized by the 
three antid mAbs were spatially separated or 
overlapping, an ELISA double antibinding assay 
was applied as described in [25]. This method relies 
on the estimation of the number of epitopes on the 
antigen simultaneously available to a pair of an- 
tibodies. The additivity index, AI, is expressed for 
a pair of antibodies by the formula 
where AI, AZ and Al+2 are the absorbancies 
observed in ELISA for the first antibody alone, the 
second antibody alone, and the two antibodies 
together. If antibodies bind to distinct sites, AI is 
expected to be equal or close to 100%. This is in- 
deed the case for the pairs mAb 622-mAb 6195 and 
mAb 622-mAb S239, but not for the pair mAb 
6195mAb 6239 (table 1). In other words, the 
epitope recognized by mAb 622 differs from those 
recognized by mAb 6195 and mAb 6239. On the 
other hand, the epitopes recognized by mAb 6195 
and mAb 8239 are probably close to each other, if 
not overlapping. 
Further mapping data were obtained by deter- 
mination of the immunoreactivity of peptides 
resulting from cleavage of the J-subunit. CNBr 
cleavage at the two methionyl residues, Met 16 and 
Met 102, present in beef heart 6 [26] generated 
three peptides spanning Ala-1-Met-16, Ser-17- 
Met-102, and Leu-103-Glu-146 and referred to as 
CBl, CB2 or CB3, respectively (fig.3). Both mAb 
6195 and mAb 6239 reacted against CBl, showing 
a close proximity or possibly an overlapping of the 
two respective epitopes, in agreement with the 
result of the additivity test. mAb 622 reacted 
against CB2 and the Ala-l-Glu-68 fragment ob- 
tained by digestion of 6 by the Staphylococcus 
aureus V8 protease. By combining the results of 
enzymatic and chemical cleavages, the epitope 
reacting against mAb 622 was therefore localized 
more precisely between Ser-17 and Glu-68 (fig.4). 
In summary, the present results show that the N- 
terminal portion of the &subunit is freely accessi- 
ble in isolated 6 and also in 6 associated to the 
other subunits of the Fi sector, either in Fi or the 
Fo-Fi complex. On the other hand, the portion of 
the 6 chain spanning Ser-17-Glu-68 is partially 
hidden in Fi or the Fo-Fi complex, probably 
because of the steric hindrance generated by con- 
tact with the other subunits of Fi. The epitopes of 
the S-subunit recognized by the three mAbs do not 
seem to be involved in the catalytic events of ATP 
hydrolysis. 
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